These data further reinforce the emergence of ADCETRIS as a standard of care for patients with Hodgkin lymphoma who experience relapse or disease progression following salvage therapy
of intraprostatic failure after radical external-beam radiotherapy for prostate cancer: A review.
Seventy-seven percent also failed one or more courses of additional salvage therapy
beyond temozolomide and Avastin prior to VAL-083.
Treatments described include autologous hematopoietic stem cell transplantation, allogenic stem cell transplantation, and non-transplant-based salvage therapy
A 2010 retrospective study of 65 patients (55 first-line HIFU treatments, 10 salvage therapy
after radiotherapy), led by Thomas Ripert, is less positive.
is given in the context of a detectable PSA after initial surgery or a rising PSA profile after initial radiation therapy.
Posaconazole is effective as salvage therapy
in zygomycosis: a retrospective summary of 91 cases.
Despite his prominent role in these campaigns, Steve was the site principal investigator of a large number of pharmaceutical industry trials, which allowed many of his patients to access antiretrovirals before the public sector scale-up and, latterly, access to drugs potentially useful for salvage therapy
Patients with colorectal cancer liver metastases who are resistant or intolerant of chemotherapy should be considered for salvage therapy
using 90Y resin microspheres combined with 5FU-based chemotherapy," said Dr Alain Hendlisz, Head of Digestive Oncology and Gastroenterology at Institut Jules Bordet Universite Libre de Bruxelles, Brussels, Belgium, and principal investigator of the study.
The uptake of these agents may depend more on drug interaction concerns than efficacy differences; for example, the DUET trials showed that the majority of treatment-experienced patients were able to suppress viral replication when darunavir was used with etravirine as salvage therapy
The improvement in prostate cancer--specific survival was threefold with salvage therapy
alone (hazard ratio 0.
Marr et al retrospectively studied the combination of caspofungin and voriconazole as salvage therapy
in 47 patients with proven or probable invasive aspergillosis (including extrapulmonary disease) who had failed to respond to amphotericin B.